These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8359732)
1. [Diagnostic value of mucin-like associated antigen (MCA) in neoplasms of the mammary gland]. Kopczyński Z; Stachowicz A; Kociałkowski K; Grodecka-Gazdecka S Ginekol Pol; 1993 Feb; 64(2):87-92. PubMed ID: 8359732 [TBL] [Abstract][Full Text] [Related]
2. [Evaluation of an immunoenzymatic assay for determining estrogen and progesterone receptors in breast tumors]. Kopczyński Z; Stachowicz A; Kociałkowski K; Grodecka-Gazdecka S; Faryńska E Ginekol Pol; 1992; 63(10):528-33. PubMed ID: 1305562 [TBL] [Abstract][Full Text] [Related]
3. The value of tissue polypeptide specific antigen TPS determination in serum of women with breast cancer comparison to mucin-like associated antigen MCA and CA 15-3 antigen. Kopczyński Z; Thielemann A Eur J Gynaecol Oncol; 1998; 19(5):503-7. PubMed ID: 9863926 [TBL] [Abstract][Full Text] [Related]
4. Mucin-like carcinoma associated antigen (MCA) at presentation with breast cancer. Horgan PG; Byrne J; O'Donoghue J; Mooney E; Grimes H; Given HF Ir J Med Sci; 1997; 166(4):215-6. PubMed ID: 9394068 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer. Rasoul-Rockenschaub S; Zielinski CC; Kubista E; Vavra N; Pospischil E; Staffen A; Czerwenka K; Aiginger P; Spona J Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1067-72. PubMed ID: 2759162 [TBL] [Abstract][Full Text] [Related]
6. Mucin-like cancer-associated antigen (MCA) compared with CA 15-3 in advanced breast cancer. Steger GG; Mader R; Derfler K; Moser K; Dittrich C Klin Wochenschr; 1989 Aug; 67(16):813-7. PubMed ID: 2796251 [TBL] [Abstract][Full Text] [Related]
7. MCA performance in preoperative breast cancer patients. Donadeo A; Micelli G; Quaranta M; Atlante A; Schittulli F Anticancer Res; 1995; 15(2):527-9. PubMed ID: 7763034 [TBL] [Abstract][Full Text] [Related]
8. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study. Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729 [TBL] [Abstract][Full Text] [Related]
9. MCA serum determination in breast carcinoma patients for the diagnosis of bone metastases. Dominguez-Gadea L; Martin-Curto LM; Crespo A; Avila C Int J Biol Markers; 1993; 8(4):203-7. PubMed ID: 8138659 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of the new tumor marker MCA in the follow-up of patients with mammary carcinoma. Müller-Brand J; Mäcke H Int J Biol Markers; 1993; 8(2):130-2. PubMed ID: 8366296 [TBL] [Abstract][Full Text] [Related]
11. A mucinous-like carcinoma-associated antigen (MCA) in the tissue and blood of patients with primary breast cancer. Bombardieri E; Gion M; Mione R; Dittadi R; Bruscagnin G; Buraggi G Cancer; 1989 Feb; 63(3):490-5. PubMed ID: 2643453 [TBL] [Abstract][Full Text] [Related]
12. [Serum concentrations of the MCA tumor marker during pregnancy]. Pütz I; Lang G; Winkler M; Rath W Zentralbl Gynakol; 1996; 118(7):409-11. PubMed ID: 8766103 [TBL] [Abstract][Full Text] [Related]
13. Preliminary study on serum levels of mucinous like cancer antigen (MCA) in patients with breast disease: comparison with CEA. Boccardo F; Bombardieri E; Zanardi S; Valenti G; Zanaboni F; Valtolina M; Seregni E; Crippa F Int J Biol Markers; 1991; 6(1):12-20. PubMed ID: 1856512 [TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of mucinous carcinoma-associated antigen (MCA) tests in breast carcinomas. Günes I; Miserez AR; Müller-Brand J; Maecke H Int J Biol Markers; 1992; 7(4):222-4. PubMed ID: 1491177 [TBL] [Abstract][Full Text] [Related]
15. Mucin-like carcinoma-associated antigen (MCA) in tissue and serum of patients with breast cancer: clinical applications in prognosis and disease monitoring. Molina R; Jo J; Filella X; Zanon G; Grau JJ; Joseph J; Bedini JL; Biete A; Ballesta AM Int J Biol Markers; 1993; 8(2):113-23. PubMed ID: 8366294 [TBL] [Abstract][Full Text] [Related]
16. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA). Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221 [TBL] [Abstract][Full Text] [Related]
17. Clinical value of a mucin-like carcinoma-associated antigen in monitoring breast cancer patients in comparison with CA 15-3. Miserez AR; Günes I; Müller-Brand J; Walther E; Fridrich R; Mäcke H Eur J Cancer; 1991; 27(2):126-31. PubMed ID: 1827273 [TBL] [Abstract][Full Text] [Related]
18. Comparison of tumour markers TAG 12 with CA 15-3 and MCA in breast cancer diagnosis. Eskelinen M; Hippelainen M; Salmela E; Paajanen H; Carlsson L; Jonsson P; Alhava E Anticancer Res; 1992; 12(1):39-42. PubMed ID: 1567179 [TBL] [Abstract][Full Text] [Related]
19. MUC3 and MCA serum levels and steroid receptor content in breast cancer. Quaranta M; Coviello M; Daniele A; Abbate I; Durrant LG; Paradiso A; Schittulli F Int J Biol Markers; 2004; 19(2):109-14. PubMed ID: 15255542 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of mucinous-like cancer antigen (MCA) in women with breast disease: preliminary results. Valenti G; Zanardi S; Valtolina M; Bombardieri E; Boccardo F Cancer Detect Prev; 1991; 15(4):285-9. PubMed ID: 1794135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]